½ÃÀ庸°í¼­
»óǰÄÚµå
1518343

ÁÖÀÔ ÆßÇÁ ½ÃÀå : À¯Çüº°, ä³Îº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(-2030³â)

Infusion Pumps Market by Type (Volumetric, Syringe, Insulin, Ambulatory Implantable), Channel (Single, Multi) Application (Oncology, Pain, Diabetes, Hematology, Pediatrics) End User (Hospital, Ambulatory Care) - Global Forecast to 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Meticulous Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 230 Pages | ¹è¼Û¾È³» : 5-7ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼ö¾× ÆßÇÁ ½ÃÀåÀº 2023-2030³â 8.3%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î ¼ºÀåÇÏ¿© 2030³â±îÁö 259¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÌ º¸°í¼­´Â ±¤¹üÀ§ÇÑ 2Â÷ ¹× 1Â÷ Á¶»ç, ½ÃÀå ½Ã³ª¸®¿À¿¡ ´ëÇÑ ½ÉÃþ ºÐ¼®À» ÅëÇØ ÁÖ¿ä »ê¾÷ ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ¹× °úÁ¦¿¡ ´ëÇÑ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

¿Ü·¡¿ë ¼ö¾× ÆßÇÁ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ³ëÀÎ Àα¸ÀÇ ±ÞÁõ¿¡ µû¸¥ ¸¸¼ºÁúȯ À¯º´·ü Áõ°¡, ¼ö¼ú °Ç¼ö Áõ°¡, ÀçÅÃÀÇ·á¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡ µîÀÌ ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ±×·¯³ª ¼ö¾× ÆßÇÁÀÇ ÀæÀº Á¦Ç° ¸®ÄÝ, Àç»ý ¼ö¾× ÆßÇÁ ¹× ´ë¿© ¼ö¾× ÆßÇÁÀÇ Ã¤Åà Áõ°¡, ¾ö°ÝÇÑ ±ÔÁ¦ ¿ä°Ç µîÀÌ ÀÌ ½ÃÀåÀÇ ¼ºÀåÀ» ÀúÇØÇϰí ÀÖ½À´Ï´Ù.

¶ÇÇÑ, ½ÅÈï ½ÃÀå°ú IoT ¼ö¾× ÆßÇÁ¿Í °°Àº Ư¼ö ¼ö¾× ½Ã½ºÅÛÀÇ Ã¤Åà Ȯ´ë´Â ¼ö¾× ÆßÇÁ ½ÃÀå ÁøÃâ±â¾÷µé¿¡°Ô Å« ºñÁî´Ï½º ±âȸ¸¦ °¡Á®´ÙÁÖ°í ÀÖ½À´Ï´Ù. ±×·¯³ª Åõ¾à ¿À·ù Áõ°¡¿Í º´¿ø ³» ¹«¼± ¿¬°áÀÇ ºÎÁ·Àº ÀÌ ½ÃÀåÀÇ ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â µµÀü °úÁ¦ÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå ÀλçÀÌÆ®

  • °³¿ä
  • ¼ºÀå ÃËÁø¿äÀÎ
  • ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ±âȸ
  • °úÁ¦
  • PorterÀÇ Five Forces ºÐ¼®
  • ±ÔÁ¦ ºÐ¼®
  • »ç·Ê ¿¬±¸/ÀÌ¿ë »ç·Ê

Á¦5Àå ÁÖÀÔ ÆßÇÁ ½ÃÀå ±Ô¸ð¡¤µ¿Ç⠺м® : Á¦Ç°º°

  • °³¿ä
  • Àåºñ
    • À¯Çüº°
      • ¿ë·®Çü ÁÖÀÔ ÆßÇÁ
      • ½Ã¸°Áö ÁÖÀÔ ÆßÇÁ
      • Àν¶¸° ÁÖÀÔ ÆßÇÁ
      • ¿Ü·¡¿ë ÁÖÀÔ ÆßÇÁ
        • ÀÏȸ¿ë ÁÖÀÔ ÆßÇÁ
        • È­Çпä¹ý¿ë ÁÖÀÔ ÆßÇÁ
      • °æÀå¿ë ÁÖÀÔ ÆßÇÁ
      • PCA ÁÖÀÔ ÆßÇÁ
      • À̽ÄÇü ÁÖÀÔ ÆßÇÁ
    • ¸ðµåº°
      • ¼öµ¿ ÁÖÀÔ ÆßÇÁ
      • ÀÚµ¿ ÁÖÀÔ ÆßÇÁ
  • ÁÖÀÔ ÆßÇÁ¿ë ºÎ¼Óǰ/¼Ò¸ðǰ

Á¦6Àå ÁÖÀÔ ÆßÇÁ ½ÃÀå ±Ô¸ð¡¤µ¿Ç⠺м® : ä³Îº°

  • °³¿ä
  • ´ÜÀÏ Ã¤³Î ÁÖÀÔ ÆßÇÁ
  • ¸ÖƼ ä³Î ÁÖÀÔ ÆßÇÁ

Á¦7Àå ÁÖÀÔ ÆßÇÁ ½ÃÀå ±Ô¸ð¡¤µ¿Ç⠺м® : ¿ëµµº°

  • °³¿ä
  • ´ç´¢º´ °ü¸®
  • Á¾¾çÇÐ
  • ÅëÁõ °ü¸®
  • Ç÷¾×ÇÐ
  • ½Å»ý¾Æ°ú/¼Ò¾Æ°ú
  • ¼ÒÈ­±â ³»°ú

Á¦8Àå ÁÖÀÔ ÆßÇÁ ½ÃÀå ±Ô¸ð¡¤µ¿Ç⠺м® : ÃÖÁ¾»ç¿ëÀÚº°

  • °³¿ä
  • º´¿ø ¹× Ŭ¸®´Ð
  • ÀçÅÃÄ¡·á
  • Çмú±â°ü ¹× ¿¬±¸±â°ü
  • ¿Ü·¡ ÀÇ·á
  • ¿ä¾ç½Ã¼³

Á¦9Àå ÁÖÀÔ ÆßÇÁ ½ÃÀå ±Ô¸ð¡¤µ¿Ç⠺м® : Áö¿ªº°

  • °³¿ä
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ¿µ±¹
    • ½ºÆäÀÎ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦10Àå °æÀï ºÐ¼®

  • °³¿ä
  • ÁÖ¿ä ¼ºÀå Àü·«
  • °æÀï º¥Ä¡¸¶Å·
  • °æÀï ´ë½Ãº¸µå
    • ¾÷°è ¸®´õ
    • Â÷º°È­ ¿äÀÎ
    • ÁöµµÀÚ
    • ½Å±Ô ±â¾÷
  • ½ÃÀå Á¡À¯À² ºÐ¼®/½ÃÀå ¼øÀ§(2022³â)

Á¦11Àå ±â¾÷ °³¿ä(»ç¾÷ °³¿ä, À繫 °³¿ä, Á¦Ç° Æ÷Æ®Æú¸®¿À, Àü·«Àû Àü°³)

  • Becton, Dickinson and Company(BD)(¹Ì±¹)
  • B. Braun SE(µ¶ÀÏ)
  • Fresenius SE&Co. KGaA.(µ¶ÀÏ)
  • ICU Medical, Inc.(¹Ì±¹)
  • Medtronic plc(¾ÆÀÏ·£µå)
  • MOOG Inc.(¹Ì±¹)
  • Terumo Corporation(ÀϺ»)
  • F. Hoffmann-LA Roche Ltd(½ºÀ§½º)
  • Insulet Corporation(¹Ì±¹)
  • Baxter International Inc.(¹Ì±¹)

(ÁÖ : SWOT ºÐ¼®Àº ÁÖ¿ä 5°³»ç¿¡ ´ëÇØ ±âÀç)

Á¦12Àå ºÎ·Ï

LSH 24.07.30

Infusion Pumps Market Size, Share, Forecast, & Trends Analysis by Type (Volumetric, Syringe, Insulin, Ambulatory [Disposable, Chemo], Implantable), Channel (Single, Multi), Application (Oncology, Pain, Diabetes, Pediatrics), End User-Global Forecast to 2030

The infusion pumps market is projected to reach $25.9 billion by 2030 at a CAGR of 8.3% from 2023 to 2030.

Succeeding extensive secondary and primary research and an in-depth analysis of the market scenario, the report provides an analysis of key industry drivers, restraints, opportunities, and challenges.

The growth of this market is driven by rising demand for ambulatory infusion pumps, the increasing incidence of chronic diseases along with rapid growth in the geriatric population, the growing number of surgical procedures performed, and increased awareness regarding home healthcare. However, frequent product recalls of infusion pumps, the increasing adoption of refurbished and rental infusion pumps, and stringent regulatory requirements restrain the growth of this market.

Furthermore, emerging markets and the growing adoption of specialty infusion systems, such as IoT infusion pumps, are generating significant opportunities for players in the infusion pumps market. However, the increasing incidence of medication errors and lack of wireless connectivity in hospitals are challenges impacting the growth of this market.

The report offers a competitive landscape based on an extensive assessment of the product portfolios, geographic presence, and key strategic developments of leading market players during the last four years (2020-2023). The key players operating in the infusion pumps market are Becton, Dickinson and Company (BD), B. Braun SE (Germany), Baxter International Inc. (U.S.), Fresenius SE&Co. KGaA. (Germany), ICU Medical, Inc. (U.S.), Medtronic plc (Ireland), MOOG Inc. (U.S.), Terumo Corporation (Japan), F. Hoffmann-LA Roche Ltd (Switzerland), and Insulet Corporation (U.S.).

Based on type, in 2023, the infusion pump accessories/consumables segment is expected to account for the largest share of the infusion pumps market. The recurrent use and repeat purchases of accessories/consumables for infusion therapy support the segment's large share.

Based on channel, in 2023, the multi-channel infusion pumps segment is expected to account for the larger share of the infusion pumps market owing to factors such as the rising demand for technologically advanced infusion pumps, the need for precise delivery of multiple drugs in cases of chronic diseases, rising awareness regarding infusion pumps, and the growing demand for advanced infusion pumps in home healthcare.

Based on application, in 2023, the oncology segment is expected to account for the largest share of the infusion pumps market due to the increasing prevalence of cancer and rising demand for the controlled dispensing of drugs in the body for chemotherapy. Additionally, portable infusion pumps allow patients to receive chemotherapy in their homes, supporting the segment's growth.

Based on end user, in 2023, the hospitals & clinics segment is expected to account for the largest share of the infusion pumps market. Factors such as the large volume of patients served by hospitals, the top line serving a large volume of patients, and the increasing patient pool contribute to the segment's large market share.

An in-depth analysis of the geographical scenario in the infusion pumps market provides detailed qualitative and quantitative insights into five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2023, North America is expected to account for the largest share of the infusion pumps market. Further, in 2023, the U.S. is expected to account for the major share of the infusion pumps market in North America. However, Asia-Pacific is projected to witness the fastest growth during the forecast period due to increased government support for technology adoption in the healthcare sector, rising investments in improving healthcare infrastructure, and increasing awareness and literacy among the population. Furthermore, the growing presence of key companies is also boosting market growth in the region.

Scope of the Report:

Infusion Pumps Market Assessment-by Type

  • Devices
    • By Type
  • Volumetric Infusion Pumps
  • Syringe Infusion Pumps
  • Insulin Infusion Pumps
  • Ambulatory Infusion Pumps
  • Disposable Infusion Pumps
  • Chemotherapy Infusion Pumps
  • Enteral Infusion Pumps
  • PCA Infusion Pumps
  • Implantable Infusion Pumps
    • By Mode
  • Manual Infusion Pumps
  • Automatic Infusion Pumps
  • Infusion Pump Accessories/Consumables

Infusion Pumps Market Assessment-by Channel

  • Single-channel Infusion Pumps
  • Multi-channel Infusion Pumps

Infusion Pumps Market Assessment-by Application

  • Diabetes Management
  • Oncology
  • Pain Management
  • Hematology
  • Neonatology/Pediatrics
  • Gastroenterology

Infusion Pumps Market Assessment-by End User

  • Hospitals & Clinics
  • Home Health Care
  • Academic & Research Institutes
  • Ambulatory Care Settings
  • Nursing Homes

Infusion Pumps Market Assessment-by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • U.K.
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific
    • China
    • Japan
    • India
    • Rest of Asia-Pacific (RoAPAC)
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America (RoLATAM)
  • Middle East & Africa

TABLE OF CONTENTS

1. Introduction

  • 1.1. Market Definition and Scope
  • 1.2. Market Ecosystem
  • 1.3. Currency and Limitations
  • 1.4. Key Stakeholders

2. Research Methodology

  • 2.1. Research Approach
  • 2.2. Process of Data Collection and Validation
    • 2.2.1. Secondary Research
    • 2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
  • 2.3. Market Sizing and Forecast
    • 2.3.1. Market Size Estimation Approach
    • 2.3.2. Growth Forecast Approach
    • 2.3.3 Market Share Analysis
  • 2.4. Assumptions for the Study

3. Executive Summary

4. Market Insights

  • 4.1. Overview
  • 4.2. Drivers
    • 4.2.1. Rising Demand for Ambulatory Infusion Pumps
    • 4.2.2. Increasing Incidence of Chronic Diseases along with the Rapid Growth in the Geriatric Population
    • 4.2.3. Growing Number of Surgical Procedures Performed
    • 4.2.4. Increase in Awareness Towards Home Healthcare
  • 4.3. Restraints
    • 4.3.1. Frequent Product Recalls of Infusion Pumps
    • 4.3.2. Increasing Adoption of Refurbished and Rental Infusion Pumps
    • 4.3.3. Stringent Regulatory Requirements for New Products
  • 4.4. Opportunities
    • 4.4.1. Emerging Markets
    • 4.4.2. Growing Adoption of Specialty Infusion Systems such as IOT Infusion Pumps
  • 4.5. Challenges
    • 4.5.1. Increasing Incidence of Medication Errors and Lack of Wireless Connectivity in Hospitals
  • 4.6. Porter's Five Forces Analysis
  • 4.7. Regulatory Analysis
  • 4.8. Case Studies/Use Cases

5. Infusion Pumps Market Size & Trend Analysis-by Product

  • 5.1. Overview
  • 5.2. Devices
    • 5.2.1. By Type
      • 5.2.1.1. Volumetric Infusion Pumps
      • 5.2.1.2. Syringe Infusion Pumps
      • 5.2.1.3. Insulin Infusion Pumps
      • 5.2.1.4. Ambulatory Infusion Pumps
        • 5.2.1.4.1. Disposable Infusion Pumps
        • 5.2.1.4.2. Chemotherapy Infusion Pumps
      • 5.2.1.5. Enteral Infusion Pumps
      • 5.2.1.6. PCA Infusion Pumps
      • 5.2.1.7. Implantable Infusion Pumps
    • 5.2.2. By Mode
      • 5.2.2.1. Manual Infusion Pumps
      • 5.2.2.2. Automatic Infusion Pumps
  • 5.3. Infusion Pump Accessories/Consumables

6. Infusion Pumps Market Size & Trend Analysis-by Channel

  • 6.1. Overview
  • 6.2. Single Channel Infusion Pumps
  • 6.3. Multi-channel Infusion Pumps

7, Infusion Pumps Market Size & Trend Analysis-by Application

  • 7.1. Overview
  • 7.2. Diabetes Management
  • 7.3. Oncology
  • 7.4. Pain Management
  • 7.5. Hematology
  • 7.6. Neonatology/Pediatrics
  • 7.7. Gastroenterology

8. Infusion Pumps Market Size & Trend Analysis-by End User

  • 8.1. Overview
  • 8.2. Hospitals & Clinics
  • 8.3. Home Health Care
  • 8.4. Academic & Research Institutes
  • 8.5. Ambulatory Care Settings
  • 8.6. Nursing Homes

9. Infusion Pumps Market Size & Trend Analysis-by Geography

  • 9.1. Overview
  • 9.2. North America
    • 9.2.1. U.S.
    • 9.2.2. Canada
  • 9.3. Europe
    • 9.3.1. Germany
    • 9.3.2. France
    • 9.3.3. Italy
    • 9.3.4. U.K.
    • 9.3.5. Spain
    • 9.3.6. Rest of Europe
  • 9.4. Asia-Pacific
    • 9.4.1. China
    • 9.4.2. Japan
    • 9.4.3. India
    • 9.4.4. Rest of Asia-Pacific
  • 9.5. Latin America
    • 9.5.1. Brazil
    • 9.5.2. Mexico
    • 9.5.3. Rest of Latin America
  • 9.6. Middle East & Africa

10. Competition Analysis

  • 10.1. Overview
  • 10.2. Key Growth Strategies
  • 10.3. Competitive Benchmarking
  • 10.4. Competitive Dashboard
    • 10.4.1. Industry Leaders
    • 10.4.2. Differentiators
    • 10.4.3. Vanguards
    • 10.4.4. Emerging Companies
  • 10.5. Market Share Analysis/Market Ranking (2022)

11. Company Profiles (Business Overview, Financial Overview, Product Portfolio, and Strategic Developments)

  • 11.1. Becton, Dickinson and Company (BD) (U.S.)
  • 11.2. B. Braun SE (Germany)
  • 11.3. Fresenius SE&Co. KGaA. (Germany)
  • 11.4. ICU Medical, Inc. (U.S.)
  • 11.5. Medtronic plc (Ireland)
  • 11.6. MOOG Inc. (U.S.)
  • 11.7. Terumo Corporation (Japan)
  • 11.8. F. Hoffmann-LA Roche Ltd (Switzerland)
  • 11.9. Insulet Corporation (U.S.)
  • 11.10. Baxter International Inc. (U.S.)

(Note: SWOT analysis is provided for the top 5 companies.)

12. Appendix

  • 12.1. Available Customization
  • 12.2. Related Reports
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦